Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Abutalib SA"'
Publikováno v:
Laboratory Medicine; Mar2008, Vol. 39 Issue 3, p147-152, 6p
Autor:
Tallman MS, Abutalib SA
Publikováno v:
Oncology (08909091); Jan2007, Vol. 21 Issue 1, p58-62, 2p
Autor:
Epperla N; The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Kumar A; Department of Internal Medicine, Office of Research, Morsani College of Medicine, University of South Florida, Tampa, Florida., Abutalib SA; Co-Director, Hematology & BMT/Cellular Therapy, Medical Director, NMDP Apheresis Midwest Program Associate Professor, Rosalind Franklin University of Medicine and Science, City of Hope, Zion, Illinois., Awan FT; Division of Hematology and Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas., Chen YB; Hematopoietic Cell Transplant & Cell Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., Gopal AK; University of Washington/Fred Hutch Cancer Center, Seattle, Washington., Holter-Chakrabarty J; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma., Kekre N; Transplantation & Cellular Therapy Program, University of Ottawa, Ottawa, Ontario, Canada., Lee CJ; Transplant and Cellular Therapy Program at Huntsman Cancer Institute, Salt Lake City, Utah., Lekakis L; University of Miami, Miami, Florida., Lin Y; Mayo Clinic, Rochester, Minnesota., Mei M; City of Hope, Duarte, California., Nathan S; Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, Illinois., Nastoupil L; University of Texas, MD Anderson Cancer Center, Houston, Texas., Oluwole O; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee., Phillips AA; Division of Hematology and Oncology, Weill Cornell Medicine, New York, New York., Reid E; Moores Cancer Center at UC San Diego Health, La Jolla, California., Rezvani AR; Division of Blood & Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, California., Trotman J; Concord Repatriation General Hospital, University of Sydney, Sydney, Australia., Zurko J; University of Wisconsin, Madison, Wisconsin., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy, Mayo Clinic, Jacksonville, Florida., Sauter CS; Division of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio., Perales MA; Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York., Locke FL; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Carpenter PA; University of Washington/Fred Hutch Cancer Center, Seattle, Washington., Hamadani M; BMT & Cellular Therapy Program, Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: mhamadani@mcw.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Sep; Vol. 29 (9), pp. 548-555. Date of Electronic Publication: 2023 Jul 05.
Autor:
Baskaran AB; Feinberg School of Medicine.; University of Chicago Medicine, University of Chicago, Chicago., Dixit KS; Department of Neurology., Sonabend AM; Department of Neurological Surgery., Horbinski CM; Chief, Neuropathology Division, Departments of Pathology and Neurosurgery., Abutalib SA; Hematology, BMT/Cellular Therapy and Clinical Apheresis Programs, Cancer Treatment Centers of America, Zion.; Rosalind Franklin University of Medicine and Science, IL., Lukas RV; Associate Chief, Neuro-Oncology Division, Department of Neurology.
Publikováno v:
The neurologist [Neurologist] 2023 May 01; Vol. 28 (3), pp. 135-142. Date of Electronic Publication: 2023 May 01.
Autor:
Furqan F; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Ahn KW; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Chen Y; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Kaur M; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Abutalib SA; Co-Director, Hematology & BMT/Cellular Therapy, Medical Director, NMDP Apheresis Midwest Program Associate Professor, Rosalind Franklin University of Medicine and Science CTCA, Part of City of Hope, Zion, Illinois, USA., Ahmed N; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, Kansas, USA., Ahmed S; Departments of Lymphoma/Myeloma and Stem Cell Transplantation/Cellular Therapy UT MD Anderson Cancer Center, Houston, Texas, USA., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA., Friedberg J; University of Rochester, Wilmot Cancer Institute, Department of Medicine., Gregory T; Colorado Blood Cancer Institute, Denver, CO and Sarah Cannon Research Institute, Nashville, Tennessee, USA., Hill L; Center for Cell and Gene Therapy, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA., Sterling C; Division of Hematologic Malignancies, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Barta SK; Division of Hematology and Medical Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Shadman M; Clinical Research Division, Fred Hutch Cancer Center and Medical Oncology Division, University of Washington, Seattle, Washington, USA., Perales MA; Department of Medicine, Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center.; Weill Cornell Medical College, New York, New York, USA., Zain J; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Herrera AF; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope National Medical Center, Duarte, California, USA., Sauter C; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, Ohio, USA., Hamadani M; BMT & Cellular Therapy Program, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Jan; Vol. 200 (1), pp. 54-63. Date of Electronic Publication: 2022 Sep 19.
Autor:
Farge D; Unité de Médecine Interne (UF04): CRMR MATHEC, Maladies Auto-immunes et Thérapie Cellulaire, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Nord-Université de Paris, Paris, France; Faculté de Médecine, Institut de Recherche St-Louis, EA-3518, Université de Paris, Paris, France; Department of Medicine, Research Institute of the McGill University Health Centre, McGill University, Montreal, QC, Canada. Electronic address: itaccme@gmail.com., Frere C; INSERM UMRS 1166, GRC 27 GRECO, DMU BioGeM, Assistance Publique Hôpitaux de Paris, Sorbonne University, Paris, France., Connors JM; Hematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Khorana AA; Taussig Cancer Institute and Case Comprehensive Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Kakkar A; Thrombosis Research Institute, London, UK; Faculty of Medical Sciences, University College London, London, UK., Ay C; Clinical Division of Hematology and Hemostaseology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Muñoz A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Brenner B; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel., Prata PH; Hematology-Transplantation Department, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Nord-Université de Paris, Paris, France., Brilhante D; Francisco Gentil Portuguese Institute of Oncology, Lisbon Center, Lisbon, Portugal., Antic D; Clinic for Hematology, Clinical Center Serbia, University of Belgrade, Belgrade, Serbia., Casais P; Instituto de Investigaciones en Salud Pública, Universidad de Buenos, Buenos Aires, Argentina., Guillermo Esposito MC; Departamento Clínico de Medicina, Manuel Quintela Clinic Hospital, Montevideo, Uruguay., Ikezoe T; Department of Hematology, Fukushima Medical University, Fukushima, Japan., Abutalib SA; Cancer Treatment Centers of America, Chicago, IL, USA., Meillon-García LA; The ABC Medical Center, Mexico City, Mexico., Bounameaux H; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Pabinger I; Clinical Division of Hematology and Hemostaseology, Department of Medicine, Medical University of Vienna, Vienna, Austria., Douketis J; Department of Medicine, McMaster University, Hamilton, ON, Canada.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2022 Jul; Vol. 23 (7), pp. e334-e347.
Autor:
Streiff MB; Division of Hematology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Abutalib SA; Cancer Treatment Centers of America, Chicago, Illinois, USA., Farge D; Unité de Médecine Interne: Maladies Auto-immunes et Pathologie Vasculaire (UF 04), Université de Paris, IRSL, Recherche clinique appliquée à l'hématologie, Paris, France.; Department of Medicine, McGill University Health Center, Montreal, Canada., Murphy M; Division of Hematology/Oncology, University of Florida, Gainesville, Florida, USA., Connors JM; Harvard Medical School, Boston, Massachusetts, USA.; Cardiovascular Medicine Division at the Brigham and Women's Hospital, Boston, Massachusetts, USA.; Brigham and Womens Hospital and Dana-Farber Cancer Institute, Boston Massachusetts, USA., Piazza G; Harvard Medical School, Boston, Massachusetts, USA.; Cardiovascular Medicine Division at the Brigham and Women's Hospital, Boston, Massachusetts, USA.; Division of Hematology/Oncology, University of Florida, Gainesville, Florida, USA.
Publikováno v:
The oncologist [Oncologist] 2021 Jan; Vol. 26 (1), pp. e24-e40. Date of Electronic Publication: 2020 Dec 04.
Autor:
Kanate AS; Section of Hematology and Oncology, West Virginia University, Morgantown, West Virginia., Kumar A; Program for Comparative Effectiveness Research, University of South Florida Morsani College of Medicine, Tampa., Dreger P; University of Heidelberg, Heidelberg, Germany., Dreyling M; Department of Medicine III, University Hospital, LMU Munich, Germany., Le Gouill S; Service d'Hématologie, Centre Hospitalo-Universitaire Nantes, Nantes, France., Corradini P; Department of Oncology and Hematology, Fondazione Istituto Nazionale dei Tumori Milano University of Milano, Milano, Italy., Bredeson C; The Ottawa Hospital Bone Marrow Transplant Programme, University of Ottawa, Ottawa, Ontario, Canada., Fenske TS; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee., Smith SM; Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois., Sureda A; Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain., Moskowitz A; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York., Friedberg JW; University of Rochester, Rochester, New York., Inwards DJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Herrera AF; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, California., Kharfan-Dabaja MA; Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida., Reddy N; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Montoto S; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Robinson SP; University Hospital Bristol NHS Foundation Trust, London, United Kingdom., Abutalib SA; Section of Hematology and Oncology, Cancer Treatment Centers of America, Zion, Illinois., Gisselbrecht C; Hôpital Saint Louis, Paris, France., Vose J; Division of Oncology & Hematology, University of Nebraska Medical Center, Omaha., Gopal A; University of Washington, Fred Hutchinson Cancer Research Center, Seattle., Shadman M; University of Washington, Fred Hutchinson Cancer Research Center, Seattle., Perales MA; Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York., Carpenter P; University of Washington, Fred Hutchinson Cancer Research Center, Seattle., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Hamadani M; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee.; Center for International Blood and Marrow Transplant Research, Wisconsin.
Publikováno v:
JAMA oncology [JAMA Oncol] 2019 May 01; Vol. 5 (5), pp. 715-722.
Autor:
Abutalib SA; Section of Hematology and Oncology, Cancer Treatment Centers of America, Zion, IL, USA., Wetzler M, Stock W
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2009 Oct; Vol. 23 (5), pp. 1099-119, vii.
Autor:
Shuaipaj T; Department of Medicine-Hematology/Oncology, University of Illinois, Chicago, IL, USA., Abutalib SA, Chen YH, Gaitonde S, Lindgren V
Publikováno v:
American journal of hematology [Am J Hematol] 2009 Mar; Vol. 84 (3), pp. 195-6.